Highlights a rare case of hemorrhagic exudative pericarditis with cardiac tamponade in a COVID-19 patient with a history of chronic lymphocytic leukemia.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to tamponade risk in CLL-COVID-19 despite mild lung involvement; leaves open need for prospective studies on pericardial complications.
A description of a COVID-19 patient with the development of exudative pericarditis complicated by cardiac tamponade is provid. A peculiarity of this case is the presence of an underlying disease in the patient (chronic lymphocytic leukemia), which was in remission for 1.5 years after chemotherapy. Another feature of the patient was the relatively small area of lung damage and the hemorrhagic nature of the pericardial effusion, which persisted for a long time. The insignificant activity of inflammatory markers was noteworthy. Possible mechanisms of development and features of the course of exudative pericarditis in the described patient, issues of diagnosis and treatment of this category of patients are discusse.
No takes yet. Share an insight, caveat, or question.
Dvoretsky et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: